Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merit Medical Systems (MMSI) Cash & Equivalents (2016 - 2025)

Merit Medical Systems (MMSI) has disclosed Cash & Equivalents for 17 consecutive years, with $446.4 million as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents rose 18.5% to $446.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $446.4 million through Dec 2025, up 18.5% year-over-year, with the annual reading at $446.4 million for FY2025, 18.5% up from the prior year.
  • Cash & Equivalents hit $446.4 million in Q4 2025 for Merit Medical Systems, up from $392.5 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $636.7 million in Q2 2024 to a low of $51.5 million in Q3 2022.
  • Historically, Cash & Equivalents has averaged $248.1 million across 5 years, with a median of $70.9 million in 2021.
  • Biggest five-year swings in Cash & Equivalents: skyrocketed 905.06% in 2023 and later tumbled 46.31% in 2025.
  • Year by year, Cash & Equivalents stood at $67.8 million in 2021, then fell by 13.79% to $58.4 million in 2022, then surged by 905.06% to $587.0 million in 2023, then crashed by 35.83% to $376.7 million in 2024, then rose by 18.5% to $446.4 million in 2025.
  • Business Quant data shows Cash & Equivalents for MMSI at $446.4 million in Q4 2025, $392.5 million in Q3 2025, and $341.8 million in Q2 2025.